| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/16/2006 | CN1817909A Double-functional blended protein |
| 08/16/2006 | CN1817908A Recombinant solvent protein derivative, its production and use |
| 08/16/2006 | CN1817907A Recombinant solvent protein, its production and use |
| 08/16/2006 | CN1817873A Flavane compound and use thereof |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1817357A Medicine for treating senile inflammation and autoimmune inflammation by extraction from Chinese herb |
| 08/16/2006 | CN1817180A Use of resveratrol for food |
| 08/16/2006 | CN1269836C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 08/16/2006 | CN1269835C Method for preparing low-polarity ginseng saponin and its aglycone by catalytic pyrolysis |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269523C Combined Chinese traditional medicine for strengthening immunity, anti virus, dispeling the effects of alcohol and preventing influenza and catch cold |
| 08/16/2006 | CN1269490C Composition of suppressing infection, and veberage and food contg. same |
| 08/16/2006 | CN1269480C Orally disintegrating tablet of loratadine and its preparation method |
| 08/16/2006 | CN1269477C Inflammation-inhibiting compounds |
| 08/16/2006 | CN1269420C Use of nutritional compositions which contain non-digestible polysaccharides |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091316 Protein induced by homogeneous blood transfusion and DNA encoding the same |
| 08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
| 08/15/2006 | US7091242 Beta-amino acid derivatives as integrin receptor antagonists |
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091215 Corticotropin-Releasing Factor (CRF) receptor antagonist |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091187 Using steroid; autoimmune disease |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/15/2006 | US7090857 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 08/15/2006 | US7090842 antigen-binding fragment comprises immunoglobulin variable region light chains and heavy chains, produced by hybridoma; fusion proteins |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | CA2285535C Benzimidazole derivative for treating allergy-related disease |
| 08/15/2006 | CA2270558C Treatment of autoimmune diseases by photochemotherapy |
| 08/15/2006 | CA2258752C Naphthyridines which affect il-4 and g-csf |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/15/2006 | CA2211612C [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/15/2006 | CA2190983C New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 08/15/2006 | CA2168193C Aryalkyl-thiadiazinones |
| 08/15/2006 | CA2150805C Antiallergic imidazo[1,2-a](pyrrolo, thieno or furano)[2,3-d]azepine derivatives |
| 08/15/2006 | CA2107439C Phospholipid derivatives containing phosphorous, arsenic, antimony or bismuth |
| 08/10/2006 | WO2006084264A2 Cd20 antibody variants and uses thereof |
| 08/10/2006 | WO2006084210A2 Hif modulating compounds and methods of use thereof |
| 08/10/2006 | WO2006084015A2 Raf inhibitor compounds and methods |
| 08/10/2006 | WO2006083908A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | WO2006082707A1 Immune enhancer |
| 08/10/2006 | WO2006082647A1 Immunopotentiator |
| 08/10/2006 | WO2006082098A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 08/10/2006 | WO2006082052A1 Synergistic combination of xolair/omalizumab/e25 with immunosuppressive agent |
| 08/10/2006 | WO2006081822A2 Minor allergen control to increase safety of immunotherapy |
| 08/10/2006 | WO2006081771A1 Artemisine (qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same |
| 08/10/2006 | WO2006081631A1 Adjuvanting material |
| 08/10/2006 | WO2006081620A1 Cd4+ cd25+ t-cells activated to a specific antigen |
| 08/10/2006 | WO2006081616A1 Classes of compounds that interact with integrins |
| 08/10/2006 | WO2006043149A9 Novel dicarboxylic acid derivatives |
| 08/10/2006 | US20060179493 Transgenically produced non-secreted proteins |
| 08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
| 08/10/2006 | US20060178418 For therapy of asthma, bronchial asthma, chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohns disease, psoraisis, uticaria, adult vernal conjunctivitis, |
| 08/10/2006 | US20060178408 Phosphodiesterases (PDE); for treating respiratory, nervous system, cardiovascular, inflammatory and allergic diseases, disorders and conditions as well as wounds |
| 08/10/2006 | US20060178399 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 08/10/2006 | US20060178368 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis |
| 08/10/2006 | US20060178359 Tricyclic compound, process for producing the same, and use |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178330 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 |
| 08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
| 08/10/2006 | US20060177898 Methods for producing modified glycoproteins |
| 08/10/2006 | US20060177819 genetic engineered polynucleotides comprising nucleotide sequences that code alphavirus replication recognition sequences, nonstructural proteins and heterologous polynucleotides; infectious, replication-defective alphavirus particles used for immunotherapy, treatment of cancer and gene delivery |
| 08/10/2006 | US20060177543 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 08/10/2006 | US20060177528 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent |
| 08/10/2006 | US20060177526 Pharmaceutical preparation |
| 08/10/2006 | US20060177517 Antiinflammtory agent and antiinflammatory medical material |
| 08/10/2006 | US20060177461 Stress proteins and uses therefor |
| 08/10/2006 | US20060177460 Administering to a patient a stress protein joined via a peptide bond to a melanoma antigen to induce or enhanc an immune response against the melanoma antigen |
| 08/10/2006 | US20060177458 Compositions of CpG and saponin adjuvants and uses thereof |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | US20060177421 Treatment of allergic conditions by use of il 21 |
| 08/10/2006 | US20060177419 Stimulating neutrophil function to treat inflammatory bowel disease |
| 08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
| 08/10/2006 | DE102005005446A1 Bruchfeste Darreichungsformen mit retardierter Freisetzung Unbreakable dosage forms with delayed release |
| 08/10/2006 | CA2830588A1 Conjugation of streptococcal capsular saccharides |
| 08/10/2006 | CA2596993A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | CA2596973A1 Raf inhibitor compounds and methods |
| 08/10/2006 | CA2596802A1 Minor allergen control to increase safety of immunotherapy |
| 08/10/2006 | CA2596754A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its uses for the treatment of inflammatory, autoimmune and proliferative diseases and disorders |
| 08/10/2006 | CA2596730A1 Adjuvanting material comprising pam2cys or pam3cys covalently linked to a metal chelating group |
| 08/10/2006 | CA2596514A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 08/10/2006 | CA2595976A1 Synergistic combination of xolair/omalizumab/e25 with immunosuppressive agent |
| 08/10/2006 | CA2595792A1 Cd20 antibody variants and uses thereof |
| 08/10/2006 | CA2593749A1 Classes of compounds that interact with integrins |
| 08/09/2006 | EP1688495A1 MU-1 member of the cytokine receptor family |
| 08/09/2006 | EP1688481A1 Bifidobacterium in the treatment of inflammatory disease |
| 08/09/2006 | EP1688439A1 Fused protein composition |
| 08/09/2006 | EP1688437A1 Antibody composition specifically binding to il-5 receptor |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688429A1 Riproximin, a novel type II ribosome-inactivating protein and uses thereof |